Matrix metalloproteinases: biologic activity and clinical implications. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM (2000) J Clin Oncol 18: 1135-49 DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Peng DF, Razvi M, Chen H, Washington K, Roessner A, Schneider-Stock R, El-Rifai W (2009) Gut 58: 5-15 Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis. Karantzali E, Schulz H, Hummel O, Hubner N, Hatzopoulos A, Kretsovali A (2008) Genome Biol 9: R65 Two transactivation mechanisms cooperate for the bulk of HIF-1-responsive gene expression. Kasper LH, Boussouar F, Boyd K, Xu W, Biesen M, Rehg J, Baudino TA, Cleveland JL, Brindle PK (2005) EMBO J 24: 3846-58 A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest. Claassen GF, Hann SR (2000) Proc Natl Acad Sci U S A 97: 9498-503 Pan-histone deacetylase inhibitor panobinostat depletes CXCR4 levels and signaling and exerts synergistic antimyeloid activity in combination with CXCR4 antagonists. Mandawat A, Fiskus W, Buckley KM, Robbins K, Rao R, Balusu R, Navenot JM, Wang ZX, Ustun C, Chong DG, Atadja P, Fujii N, Peiper SC, Bhalla K (2010) Blood 116: 5306-15 The coactivator role of histone deacetylase 3 in IL-1-signaling involves deacetylation of p65 NF-κB. Ziesché E, Kettner-Buhrow D, Weber A, Wittwer T, Jurida L, Soelch J, Müller H, Newel D, Kronich P, Schneider H, Dittrich-Breiholz O, Bhaskara S, Hiebert SW, Hottiger MO, Li H, Burstein E, Schmitz ML, Kracht M (2013) Nucleic Acids Res 41: 90-109 Coordinated changes of histone modifications and HDAC mobilization regulate the induction of MHC class II genes by Trichostatin A. Gialitakis M, Kretsovali A, Spilianakis C, Kravariti L, Mages J, Hoffmann R, Hatzopoulos AK, Papamatheakis J (2006) Nucleic Acids Res 34: 765-72 A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma. Galloway TJ, Wirth LJ, Colevas AD, Gilbert J, Bauman JE, Saba NF, Raben D, Mehra R, Ma AW, Atoyan R, Wang J, Burtness B, Jimeno A (2015) Clin Cancer Res 21: 1566-73 Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. Vilar E, Mukherjee B, Kuick R, Raskin L, Misek DE, Taylor JM, Giordano TJ, Hanash SM, Fearon ER, Rennert G, Gruber SB (2009) Clin Cancer Res 15: 2829-39 New drugs on the horizon: matrix metalloproteinase inhibitors. Rothenberg ML, Nelson AR, Hande KR (1999) Stem Cells 17: 237-40 HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. Krishnan M, Singh AB, Smith JJ, Sharma A, Chen X, Eschrich S, Yeatman TJ, Beauchamp RD, Dhawan P (2010) Oncogene 29: 305-12 Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cells. Ha K, Fiskus W, Choi DS, Bhaskara S, Cerchietti L, Devaraj SG, Shah B, Sharma S, Chang JC, Melnick AM, Hiebert S, Bhalla KN (2014) Oncotarget 5: 5637-50 Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells. Sharma A, Bhat AA, Krishnan M, Singh AB, Dhawan P (2013) Carcinogenesis 34: 2610-21 NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability. Hajduk PJ, Shuker SB, Nettesheim DG, Craig R, Augeri DJ, Betebenner D, Albert DH, Guo Y, Meadows RP, Xu L, Michaelides M, Davidsen SK, Fesik SW (2002) J Med Chem 45: 5628-39 Transforming growth factor beta mimetics: discovery of 7-[4-(4-cyanophenyl)phenoxy]-heptanohydroxamic acid, a biaryl hydroxamate inhibitor of histone deacetylase. Glaser KB, Li J, Aakre ME, Morgan DW, Sheppard G, Stewart KD, Pollock J, Lee P, O'Connor CZ, Anderson SN, Mussatto DJ, Wegner CW, Moses HL (2002) Mol Cancer Ther 1: 759-68 ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with multiple histone deacetylases and binds mSin3A through its oligomerization domain. Amann JM, Nip J, Strom DK, Lutterbach B, Harada H, Lenny N, Downing JR, Meyers S, Hiebert SW (2001) Mol Cell Biol 21: 6470-83 STAT6 activation in ulcerative colitis: a new target for prevention of IL-13-induced colon epithelial cell dysfunction. Rosen MJ, Frey MR, Washington MK, Chaturvedi R, Kuhnhein LA, Matta P, Revetta FL, Wilson KT, Polk DB (2011) Inflamm Bowel Dis 17: 2224-34 Tal1/SCL binding to pericentromeric DNA represses transcription. Wen J, Huang S, Pack SD, Yu X, Brandt SJ, Noguchi CT (2005) J Biol Chem 280: 12956-66 Gamma-glutamylmethylamide. A new intermediate in the metabolism of methylamine. Kung HF, Wagner C (1969) J Biol Chem 244: 4136-40 Effect of urease on HeLa cell vacuolation induced by Helicobacter pylori cytotoxin. Cover TL, Puryear W, Perez-Perez GI, Blaser MJ (1991) Infect Immun 59: 1264-70 Suberoylanilide hydroxamic acid (SAHA) enhances olaparib activity by targeting homologous recombination DNA repair in ovarian cancer. Konstantinopoulos PA, Wilson AJ, Saskowski J, Wass E, Khabele D (2014) Gynecol Oncol 133: 599-606 Panobinostat sensitizes cyclin E high, homologous recombination-proficient ovarian cancer to olaparib. Wilson AJ, Sarfo-Kantanka K, Barrack T, Steck A, Saskowski J, Crispens MA, Khabele D (2016) Gynecol Oncol 143: 143-151 Role of HDAC3 on p53 expression and apoptosis in T cells of patients with multiple sclerosis. Zhang F, Shi Y, Wang L, Sriram S (2011) PLoS One 6: e16795 Peroxidation of polyunsaturated fatty acid methyl esters catalyzed by N-methyl benzohydroxamic acid: a new and convenient method for selective synthesis of hydroperoxides and alcohols. Punta C, Rector CL, Porter NA (2005) Chem Res Toxicol 18: 349-56 Evaluation of long-term transgene expression in piggyBac-modified human T lymphocytes. Nakazawa Y, Saha S, Galvan DL, Huye L, Rollins L, Rooney CM, Wilson MH (2013) J Immunother 36: 3-10 Pharmacologic and genetic manipulation of MMP-2 and -9 affects retinal neovascularization in rodent models of OIR. Barnett JM, McCollum GW, Fowler JA, Duan JJ, Kay JD, Liu RQ, Bingaman DP, Penn JS (2007) Invest Ophthalmol Vis Sci 48: 907-15 Inhibition of bacteriophage lambda protein phosphatase by organic and oxoanion inhibitors. Reiter NJ, White DJ, Rusnak F (2002) Biochemistry 41: 1051-9 Drug-induced inactivation or gene silencing of class I histone deacetylases suppresses ovarian cancer cell growth: implications for therapy. Khabele D, Son DS, Parl AK, Goldberg GL, Augenlicht LH, Mariadason JM, Rice VM (2007) Cancer Biol Ther 6: 795-801 Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. Mittal MK, Myers JN, Bailey CK, Misra S, Chaudhuri G (2010) Mol Biol Rep 37: 1221-7 Epigenetic silencing of somatostatin in gastric cancer. Jackson K, Soutto M, Peng D, Hu T, Marshal D, El-Rifai W (2011) Dig Dis Sci 56: 125-30
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.